{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:19:33Z","timestamp":1791980373691,"version":"4.4.0"},"reference-count":40,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":2905,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To investigate the associations of metformin, serum vitamin B12, calcium supplements, and cognitive impairment in patients with diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Participants were recruited from the Primary Research in Memory (PRIME) clinics study, the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging, and the Barwon region of southeastern Australia. Patients with Alzheimer disease (AD) (n = 480) or mild cognitive impairment (n = 187) and those who were cognitively intact (n = 687) were included; patients with stroke or with neurodegenerative diseases other than AD were excluded. Subgroup analyses were performed for participants who had either type 2 diabetes (n = 104) or impaired glucose tolerance (n = 22).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Participants with diabetes (n = 126) had worse cognitive performance than participants who did not have diabetes (n = 1,228; adjusted odds ratio 1.51 [95% CI 1.03\u20132.21]). Among participants with diabetes, worse cognitive performance was associated with metformin use (2.23 [1.05\u20134.75]). After adjusting for age, sex, level of education, history of depression, serum vitamin B12, and metformin use, participants with diabetes who were taking calcium supplements had better cognitive performance (0.41 [0.19\u20130.92]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Metformin use was associated with impaired cognitive performance. Vitamin B12 and calcium supplements may alleviate metformin-induced vitamin B12 deficiency and were associated with better cognitive outcomes. Prospective trials are warranted to assess the beneficial effects of vitamin B12 and calcium use on cognition in older people with diabetes who are taking metformin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc13-0229","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T23:56:03Z","timestamp":1378425363000},"page":"2981-2987","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":349,"title":["Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin"],"prefix":"10.2337","volume":"36","author":[{"given":"Eileen M.","family":"Moore","sequence":"first","affiliation":[{"name":"The University of Melbourne, Department of Psychiatry, Parkville, Victoria, Australia"},{"name":"Barwon Health, Geelong, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair G.","family":"Mander","sequence":"additional","affiliation":[{"name":"Barwon Health, Geelong, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ames","sequence":"additional","affiliation":[{"name":"The University of Melbourne, Department of Psychiatry, Parkville, Victoria, Australia"},{"name":"National Ageing Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Kotowicz","sequence":"additional","affiliation":[{"name":"Barwon Health, Geelong, Victoria, Australia"},{"name":"Deakin University School of Medicine, Waurn Ponds, Victoria, Australia"},{"name":"North West Academic Centre, The University of Melbourne, Sunshine, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross P.","family":"Carne","sequence":"additional","affiliation":[{"name":"Barwon Health, Geelong, Victoria, Australia"},{"name":"Deakin University School of Medicine, Waurn Ponds, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Brodaty","sequence":"additional","affiliation":[{"name":"Centre for Healthy Brain Ageing, University of New South Wales, School of Psychiatry, Sydney, Australia"},{"name":"Aged Care Psychiatry, Prince of Wales Hospital, Randwick, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Woodward","sequence":"additional","affiliation":[{"name":"Austin Health, Heidelberg Repatriation Hospital, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn","family":"Boundy","sequence":"additional","affiliation":[{"name":"The Queen Elizabeth Hospital, Woodville South, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Ellis","sequence":"additional","affiliation":[{"name":"The University of Melbourne, Department of Psychiatry, Parkville, Victoria, Australia"},{"name":"National Ageing Research Institute, Parkville, Victoria, Australia"},{"name":"Mental Health Research Institute, The University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley I.","family":"Bush","sequence":"additional","affiliation":[{"name":"Mental Health Research Institute, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel G.","family":"Faux","sequence":"additional","affiliation":[{"name":"Mental Health Research Institute, The University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Martins","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research & Care, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia"},{"name":"Sir James McCusker Alzheimer\u2019s Disease Research Unit (Hollywood Private Hospital), Neurosciences Unit, Health Department of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Szoeke","sequence":"additional","affiliation":[{"name":"National Ageing Research Institute, Parkville, Victoria, Australia"},{"name":"Preventative Health Flagship, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rowe","sequence":"additional","affiliation":[{"name":"Austin PET Centre, Austin Hospital, Heidelberg, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Watters","sequence":"additional","affiliation":[{"name":"Barwon Health, Geelong, Victoria, Australia"},{"name":"Deakin University School of Medicine, Waurn Ponds, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the AIBL Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,9,14]]},"reference":[{"key":"2022031221333825200_B1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/jech.2008.080382","article-title":"Trends in the prevalence and incidence of diabetes in the UK: 1996-2005","volume":"63","author":"Gonz\u00e1lez","year":"2009","journal-title":"J Epidemiol Community Health"},{"key":"2022031221333825200_B2","first-page":"385","article-title":"Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study","volume-title":"Diabet Med","author":"Monesi","year":"2012"},{"key":"2022031221333825200_B3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1478-7954-8-29","article-title":"Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence","volume":"8","author":"Boyle","year":"2010","journal-title":"Popul Health Metr"},{"key":"2022031221333825200_B4","doi-asserted-by":"crossref","first-page":"e37260","DOI":"10.1371\/journal.pone.0037260","article-title":"Diabetes and pre-diabetes as determined by glycated haemoglobin A1c and glucose levels in a developing southern Chinese population","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"2022031221333825200_B5","volume-title":"American Samoa NCD Risk Factors STEPS Report","author":"Maga","year":"2007"},{"key":"2022031221333825200_B6","first-page":"405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume-title":"BMJ","author":"Stratton","year":"2000"},{"key":"2022031221333825200_B7","first-page":"156","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis","volume-title":"Diabetologia","author":"Stratton","year":"2001"},{"key":"2022031221333825200_B8","first-page":"977","article-title":"The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume-title":"New Engl J Med","year":"1993"},{"key":"2022031221333825200_B9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000265552","article-title":"Diabetes is associated with increased rate of cognitive decline in questionably demented elderly","volume":"29","author":"Ravona-Springer","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2022031221333825200_B10","first-page":"505","article-title":"Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders","volume-title":"Biol Psychiatry","author":"Profenno","year":"2009"},{"key":"2022031221333825200_B11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"2022031221333825200_B12","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.2337\/dc07-0650","article-title":"Changing incident diabetes regimens: a Veterans Administration cohort study from 2000 to 2005","volume":"30","author":"Huizinga","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031221333825200_B13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/aje\/kwk017","article-title":"Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies","volume":"165","author":"Proust-Lima","year":"2007","journal-title":"Am J Epidemiol"},{"key":"2022031221333825200_B14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.2.5763.685","article-title":"Vitamin-B12 status of patients on long-term metformin therapy","volume":"2","author":"Tomkin","year":"1971","journal-title":"BMJ"},{"key":"2022031221333825200_B15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejim.2007.02.013","article-title":"Clinical aspects of cobalamin deficiency in elderly patients. Epidemiology, causes, clinical manifestations, and treatment with special focus on oral cobalamin therapy","volume":"18","author":"Andr\u00e8s","year":"2007","journal-title":"Eur J Intern Med"},{"key":"2022031221333825200_B16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/bmj.3.5768.246-b","article-title":"Vitamin B 12 and metformin","volume":"3","author":"Stowers","year":"1971","journal-title":"BMJ"},{"key":"2022031221333825200_B17","doi-asserted-by":"crossref","first-page":"c2181","DOI":"10.1136\/bmj.c2181","article-title":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial","volume":"340","author":"de Jager","year":"2010","journal-title":"BMJ"},{"key":"2022031221333825200_B18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2337\/dc09-0606","article-title":"Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy","volume":"33","author":"Wile","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031221333825200_B19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2337\/diacare.23.9.1227","article-title":"Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin","volume":"23","author":"Bauman","year":"2000","journal-title":"Diabetes Care"},{"key":"2022031221333825200_B20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/biof.148","article-title":"Calcium signaling in cognition and aging-dependent cognitive decline","volume":"37","author":"Oliveira","year":"2011","journal-title":"Biofactors"},{"key":"2022031221333825200_B21","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1073\/pnas.0807991106","article-title":"Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer\u2019s amyloid peptides via up-regulating BACE1 transcription","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031221333825200_B22","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","article-title":"Metformin, other antidiabetic drugs, and risk of Alzheimer\u2019s disease: a population-based case-control study","volume":"60","author":"Imfeld","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"2022031221333825200_B23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","article-title":"Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice","volume":"101","author":"Li","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"2022031221333825200_B24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2012.03.016","article-title":"Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2022031221333825200_B25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-2011-101524","article-title":"Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin","volume":"24","author":"Hsu","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"2022031221333825200_B26","first-page":"1086","article-title":"Patients in Australian Memory Clinics: baseline characteristics and predictors of decline at six months","volume-title":"Int Psychogeriatr","author":"Brodaty","year":"2011"},{"key":"2022031221333825200_B27","first-page":"672","article-title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer\u2019s disease","volume-title":"Int Psychogeriatr","author":"Ellis","year":"2009"},{"key":"2022031221333825200_B28","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","article-title":"Population-based norms for the Mini-Mental State Examination by age and educational level","volume":"269","author":"Crum","year":"1993","journal-title":"JAMA"},{"key":"2022031221333825200_B29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/(SICI)1099-1166(1998100)13:10<661::AID-GPS838>3.0.CO;2-0","article-title":"Interpretation of Mini-Mental State Examination scores in community-dwelling elderly and geriatric neuropsychiatry patients","volume":"13","author":"Iverson","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"key":"2022031221333825200_B30","volume-title":"National Evidence Based Guideline for Blood Glucose Control in Type 2 Diabetes","author":"Colagiuri","year":"2009"},{"key":"2022031221333825200_B31","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/heartjnl-2011-301345","article-title":"Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg)","volume":"98","author":"Li","year":"2012","journal-title":"Heart"},{"key":"2022031221333825200_B32","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"2022031221333825200_B33","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women\u2019s Health Initiative limited access dataset and meta-analysis","volume":"342","author":"Bollanc","year":"2011","journal-title":"BMJ"},{"key":"2022031221333825200_B34","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.2215\/CJN.05860809","article-title":"Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population","volume":"5","author":"West","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022031221333825200_B35","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2011-3328","article-title":"Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials","volume":"97","author":"Rejnmark","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221333825200_B36","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes","volume":"44","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"key":"2022031221333825200_B37","first-page":"287","article-title":"Type 2 diabetes mellitus as a conformational disease","volume":"6","author":"Hayden","year":"2005","journal-title":"JOP"},{"key":"2022031221333825200_B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1041610211002511","article-title":"Cognitive impairment and vitamin B12: a review","volume":"24","author":"Moore","year":"2012","journal-title":"Int Psychogeriatr"},{"key":"2022031221333825200_B39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0009-9120(03)00062-6","article-title":"Hyperhomocysteinemia and its role in the development of atherosclerosis","volume":"36","author":"Lawrence de Koning","year":"2003","journal-title":"Clin Biochem"},{"key":"2022031221333825200_B40","volume-title":"Dementia","author":"Ames","year":"1994"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/10\/2981\/615582\/2981.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/10\/2981\/615582\/2981.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T18:49:49Z","timestamp":1647110989000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/36\/10\/2981\/30476\/Increased-Risk-of-Cognitive-Impairment-in-Patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,14]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,9,14]]},"published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc13-0229","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,14]]}}}